WIGZELL HANS LENNART RUDOLF sold 37.7% of their position (10K shares) of SAREPTA THERAPEUTICS, INC. on the open market
Open‑market sale worth $835.1K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/10/2021ACC: 0001209191-21-019670
Director
Since Nov 2018
-10K
Net shares
Net seller
$835.1K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
10K acquired · 20K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+10K
Price / share
$34.92
Trade value
$349.20K
% of position
60.5%
3/8/2021
16.52K→26.52K
Common Stock
Direct
Shares
−10K
Price / share
$83.51
Trade value
$835.10K
% of position
37.7%
3/8/2021
26.52K→16.52K
Total
Net shares
+0.00
Net value
-$485.90K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/8/2021 | M · Option Exercise | +10K | $34.92 | $349.20K | 60.5% | 16.52K | 26.52K |
| Common Stock Direct | 3/8/2021 | S · Sale | −10K | $83.51 | $835.10K | 37.7% | 26.52K | 16.52K |
| Total | +0.00 | -$485.90K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
10K shares
Shares
−10K
Strike price
34.92
Held after
0.00
Exercisable
—
3/8/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock10K shares | 3/8/2021 | M · Option Exercise | −10K | 34.92 | — | 0.00 |